SK Biopharmaceuticals Co., Ltd.(KR:326030)
â‚©89,000.00+500.00 (+0.56%)
KR:326030
SK Biopharmaceuticals Co., Ltd. Revenue
â‚©89,000.00
At close:+500.00 (+0.56%)
Want to see KR:326030 full AI Analyst Report?
SK Biopharmaceuticals Co., Ltd. (326030) Revenue
SK Biopharmaceuticals Co., Ltd. Revenue
SK Biopharmaceuticals Co., Ltd. had a revenue of 247.37B in the quarter ending Jun 30, 2026, with 8.55%. This bring the company's revenue in the last twelve months to 861.34B, Increased 9.00%. In the fiscal year ending Dec 31, 2025, SK Biopharmaceuticals Co., Ltd. had annual revenue of 706.74B with 29.06% growth.
- Revenue (ttm)
- 861.34B
- Revenue Growth
- 37.40%
- P/S Ratio
- 9.86
- Revenue/Employee
- KRW 2,932,535,104
- Employees
- 241
- Market Cap
- KRW 6.97T
Revenue Chart
SK Biopharmaceuticals Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 706.74B | 159.14B | 29.06% |
| Dec 31, 2024 | 547.60B | 192.70B | 54.30% |
| Dec 31, 2023 | 354.89B | 108.71B | 44.16% |
| Dec 31, 2022 | 246.18B | -172.47B | -41.20% |
| Dec 31, 2021 | 418.64B | 392.65B | 1510.23% |
| Dec 31, 2020 | 26.00B | -97.85B | -79.01% |
| Dec 31, 2019 | 123.85B | 122.75B | 11172.24% |
| Dec 31, 2018 | 1.10B | -84.22B | -98.71% |
| Dec 31, 2017 | 85.32B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

